
LINK . SPRINGER . COM {
}
Title:
The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome | Breast Cancer Research and Treatment
Description:
Purpose The purpose of the study was to evaluate protein expression of PD-L1 and CD20 as prognostic biomarkers of patient outcome in inflammatory breast cancer (IBC) samples. Methods PD-L1 and CD20 protein expression was measured by immunohistochemistry in 221 pretreatment IBC biopsies. PD-L1 was assessed in tumor cells (PD-L1+ tumor cells) and tumor stromal infiltrating lymphocytes (PD-L1+ TILs); CD20 was scored in tumor-infiltrating B cells. Kaplan–Meier curves and Cox proportional hazard models were used for survival analysis. Results PD-L1+ tumor cells, PD-L1+ TILs, and CD20+ TILs were found in 8%, 66%, and 62% of IBC, respectively. PD-L1+ tumor cells strongly correlated with high TILs, pathological complete response (pCR), CD20+ TILs, but marginally with breast cancer-specific survival (BCSS, P = 0.057). PD-L1+ TILs strongly correlated with high TILs, CD20+ TILs, and longer disease-free survival (DFS) in all IBC and in triple-negative (TN) IBC (P < 0.035). IBC and TN IBC patients with tumors containing both CD20+ TILs and PD-L1+ TILs (CD20+TILs/PD-L1+TILs) showed longer DFS and improved BCSS (P < 0.002) than patients lacking both, or those with either CD20+ TILs or PD-L1+ TILs alone. In multivariate analyses, CD20+TILs/PD-L1+TILs status was an independent prognostic factor for DFS in IBC (hazard ratio (HR): 0.53, 95% CI 0.37–0.77) and TN IBC (HR: 0.39 95% CI 0.17–0.88), and for BCSS in IBC (HR: 0.60 95% CI 0.43–0.85) and TN IBC (HR: 0.38 95% CI 0.17–0.83). Conclusion CD20+TILs/PD-L1+TILs status represents an independent favorable prognostic factor in IBC and TN IBC, suggesting a critical role for B cells in antitumor immune responses. Anti-PD-1/PD-L1 and B cell-activating immunotherapies should be explored in these settings.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Education
- Science
- Health & Fitness
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We can't see how the site brings in money.
Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com might be cashing in, but we can't detect the method they're using.
Keywords {🔍}
cancer, breast, article, pubmed, google, scholar, pdl, tils, inflammatory, ibc, cas, cells, central, lymphocytes, prognostic, expression, survival, patients, res, tumorinfiltrating, outcome, research, study, httpsdoiorgs, clin, medicine, ariaspulido, tumor, response, death, improved, chaher, bcss, dfs, triplenegative, access, programmed, chemotherapy, oncol, center, usa, supplementary, material, privacy, cookies, content, analysis, ciminomathews, immune, treat,
Topics {✒️}
cd20+tils/pd-l1+tils status anti-pd-l1 antibody mpdl3280a pd-l1 + tumor-infiltrating lymphocytes month download article/chapter tumour-infiltrating lymphocytes cd20+tils/pd-l1+tils triple-negative breast cancer prognostic b-cell signatures anti-pd-1/pd-l1 pd-l1+ immune cells pd-l1+ tumor cells long-term clinical benefit independent prognostic factor large population-based study methods pd-l1 breast cancer-specific survival kaplan-meier survival estimates improved patient outcome oncology meets immunology full article pdf longer disease-free survival related subjects pd-l1 expression anti–pd-1 antibody pd-l1+ tils tumor–infiltrating lymphocytes tumor-infiltrating lymphocytes inflammatory breast cancer stage iii inflammatory immunogenic cell death privacy choices/manage cookies cell-activating immunotherapies article arias-pulido human breast cancer patient outcome multiplexed quantitative analysis triple-negative subtype-specific breast antitumor immune responses ctneobc pooled analysis kaplan–meier curves check access instant access increased tils open-label disease-free survival iridium cancer net end results program end results database geyer ce jr
Questions {❓}
- Gonzalez-Angulo AM, Hennessy BT, Broglio K, Meric-Bernstam F, Cristofanilli M, Giordano SH, Buchholz TA, Sahin A, Singletary SE, Buzdar AU, Hortobagyi GN (2007) Trends for Inflammatory Breast Cancer: Is Survival Improving?
Schema {🗺️}
WebPage:
mainEntity:
headline:The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome
description:The purpose of the study was to evaluate protein expression of PD-L1 and CD20 as prognostic biomarkers of patient outcome in inflammatory breast cancer (IBC) samples. PD-L1 and CD20 protein expression was measured by immunohistochemistry in 221 pretreatment IBC biopsies. PD-L1 was assessed in tumor cells (PD-L1+ tumor cells) and tumor stromal infiltrating lymphocytes (PD-L1+ TILs); CD20 was scored in tumor-infiltrating B cells. Kaplan–Meier curves and Cox proportional hazard models were used for survival analysis. PD-L1+ tumor cells, PD-L1+ TILs, and CD20+ TILs were found in 8%, 66%, and 62% of IBC, respectively. PD-L1+ tumor cells strongly correlated with high TILs, pathological complete response (pCR), CD20+ TILs, but marginally with breast cancer-specific survival (BCSS, P = 0.057). PD-L1+ TILs strongly correlated with high TILs, CD20+ TILs, and longer disease-free survival (DFS) in all IBC and in triple-negative (TN) IBC (P < 0.035). IBC and TN IBC patients with tumors containing both CD20+ TILs and PD-L1+ TILs (CD20+TILs/PD-L1+TILs) showed longer DFS and improved BCSS (P < 0.002) than patients lacking both, or those with either CD20+ TILs or PD-L1+ TILs alone. In multivariate analyses, CD20+TILs/PD-L1+TILs status was an independent prognostic factor for DFS in IBC (hazard ratio (HR): 0.53, 95% CI 0.37–0.77) and TN IBC (HR: 0.39 95% CI 0.17–0.88), and for BCSS in IBC (HR: 0.60 95% CI 0.43–0.85) and TN IBC (HR: 0.38 95% CI 0.17–0.83). CD20+TILs/PD-L1+TILs status represents an independent favorable prognostic factor in IBC and TN IBC, suggesting a critical role for B cells in antitumor immune responses. Anti-PD-1/PD-L1 and B cell-activating immunotherapies should be explored in these settings.
datePublished:2018-06-01T00:00:00Z
dateModified:2018-06-01T00:00:00Z
pageStart:273
pageEnd:282
sameAs:https://doi.org/10.1007/s10549-018-4834-7
keywords:
PD-L1
CD20
Immuno-oncology
Inflammatory breast cancer
Triple-negative
Patient outcome
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_Fig3_HTML.gif
isPartOf:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:171
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:H. Arias-Pulido
url:http://orcid.org/0000-0003-4941-1110
affiliation:
name:Geisel School of Medicine at Dartmouth
address:
name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:A. Cimino-Mathews
affiliation:
name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
address:
name:Departments of Pathology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
type:PostalAddress
type:Organization
name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
address:
name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
type:PostalAddress
type:Organization
type:Person
name:N. Chaher
affiliation:
name:Centre Pierre et Marie Curie et Faculté de Médecine d’Alger
address:
name:Department of Pathology, Centre Pierre et Marie Curie et Faculté de Médecine d’Alger, Algiers, Algeria
type:PostalAddress
type:Organization
type:Person
name:C. Qualls
affiliation:
name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
address:
name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
type:PostalAddress
type:Organization
type:Person
name:N. Joste
affiliation:
name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
address:
name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
type:PostalAddress
type:Organization
type:Person
name:C. Colpaert
affiliation:
name:Iridium Cancer Net
address:
name:Department of Pathology, Oncology Centre, GZA Hospitals, Iridium Cancer Net, Antwerp, Belgium
type:PostalAddress
type:Organization
type:Person
name:J. D. Marotti
affiliation:
name:Geisel School of Medicine at Dartmouth
address:
name:Pathology and Laboratory Medicine, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
type:Organization
type:Person
name:M. Foisey
affiliation:
name:Geisel School of Medicine at Dartmouth
address:
name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
type:Organization
type:Person
name:E. R. Prossnitz
affiliation:
name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
address:
name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
type:PostalAddress
type:Organization
type:Person
name:L. A. Emens
affiliation:
name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
address:
name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
type:PostalAddress
type:Organization
type:Person
name:S. Fiering
affiliation:
name:Geisel School of Medicine at Dartmouth
address:
name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome
description:The purpose of the study was to evaluate protein expression of PD-L1 and CD20 as prognostic biomarkers of patient outcome in inflammatory breast cancer (IBC) samples. PD-L1 and CD20 protein expression was measured by immunohistochemistry in 221 pretreatment IBC biopsies. PD-L1 was assessed in tumor cells (PD-L1+ tumor cells) and tumor stromal infiltrating lymphocytes (PD-L1+ TILs); CD20 was scored in tumor-infiltrating B cells. Kaplan–Meier curves and Cox proportional hazard models were used for survival analysis. PD-L1+ tumor cells, PD-L1+ TILs, and CD20+ TILs were found in 8%, 66%, and 62% of IBC, respectively. PD-L1+ tumor cells strongly correlated with high TILs, pathological complete response (pCR), CD20+ TILs, but marginally with breast cancer-specific survival (BCSS, P = 0.057). PD-L1+ TILs strongly correlated with high TILs, CD20+ TILs, and longer disease-free survival (DFS) in all IBC and in triple-negative (TN) IBC (P < 0.035). IBC and TN IBC patients with tumors containing both CD20+ TILs and PD-L1+ TILs (CD20+TILs/PD-L1+TILs) showed longer DFS and improved BCSS (P < 0.002) than patients lacking both, or those with either CD20+ TILs or PD-L1+ TILs alone. In multivariate analyses, CD20+TILs/PD-L1+TILs status was an independent prognostic factor for DFS in IBC (hazard ratio (HR): 0.53, 95% CI 0.37–0.77) and TN IBC (HR: 0.39 95% CI 0.17–0.88), and for BCSS in IBC (HR: 0.60 95% CI 0.43–0.85) and TN IBC (HR: 0.38 95% CI 0.17–0.83). CD20+TILs/PD-L1+TILs status represents an independent favorable prognostic factor in IBC and TN IBC, suggesting a critical role for B cells in antitumor immune responses. Anti-PD-1/PD-L1 and B cell-activating immunotherapies should be explored in these settings.
datePublished:2018-06-01T00:00:00Z
dateModified:2018-06-01T00:00:00Z
pageStart:273
pageEnd:282
sameAs:https://doi.org/10.1007/s10549-018-4834-7
keywords:
PD-L1
CD20
Immuno-oncology
Inflammatory breast cancer
Triple-negative
Patient outcome
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_Fig3_HTML.gif
isPartOf:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:171
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:H. Arias-Pulido
url:http://orcid.org/0000-0003-4941-1110
affiliation:
name:Geisel School of Medicine at Dartmouth
address:
name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:A. Cimino-Mathews
affiliation:
name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
address:
name:Departments of Pathology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
type:PostalAddress
type:Organization
name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
address:
name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
type:PostalAddress
type:Organization
type:Person
name:N. Chaher
affiliation:
name:Centre Pierre et Marie Curie et Faculté de Médecine d’Alger
address:
name:Department of Pathology, Centre Pierre et Marie Curie et Faculté de Médecine d’Alger, Algiers, Algeria
type:PostalAddress
type:Organization
type:Person
name:C. Qualls
affiliation:
name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
address:
name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
type:PostalAddress
type:Organization
type:Person
name:N. Joste
affiliation:
name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
address:
name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
type:PostalAddress
type:Organization
type:Person
name:C. Colpaert
affiliation:
name:Iridium Cancer Net
address:
name:Department of Pathology, Oncology Centre, GZA Hospitals, Iridium Cancer Net, Antwerp, Belgium
type:PostalAddress
type:Organization
type:Person
name:J. D. Marotti
affiliation:
name:Geisel School of Medicine at Dartmouth
address:
name:Pathology and Laboratory Medicine, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
type:Organization
type:Person
name:M. Foisey
affiliation:
name:Geisel School of Medicine at Dartmouth
address:
name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
type:Organization
type:Person
name:E. R. Prossnitz
affiliation:
name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
address:
name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
type:PostalAddress
type:Organization
type:Person
name:L. A. Emens
affiliation:
name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
address:
name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
type:PostalAddress
type:Organization
type:Person
name:S. Fiering
affiliation:
name:Geisel School of Medicine at Dartmouth
address:
name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:171
Organization:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Geisel School of Medicine at Dartmouth
address:
name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
address:
name:Departments of Pathology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
type:PostalAddress
name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
address:
name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
type:PostalAddress
name:Centre Pierre et Marie Curie et Faculté de Médecine d’Alger
address:
name:Department of Pathology, Centre Pierre et Marie Curie et Faculté de Médecine d’Alger, Algiers, Algeria
type:PostalAddress
name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
address:
name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
type:PostalAddress
name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
address:
name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
type:PostalAddress
name:Iridium Cancer Net
address:
name:Department of Pathology, Oncology Centre, GZA Hospitals, Iridium Cancer Net, Antwerp, Belgium
type:PostalAddress
name:Geisel School of Medicine at Dartmouth
address:
name:Pathology and Laboratory Medicine, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
name:Geisel School of Medicine at Dartmouth
address:
name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
address:
name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
type:PostalAddress
name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
address:
name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
type:PostalAddress
name:Geisel School of Medicine at Dartmouth
address:
name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:H. Arias-Pulido
url:http://orcid.org/0000-0003-4941-1110
affiliation:
name:Geisel School of Medicine at Dartmouth
address:
name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
type:Organization
email:[email protected]
name:A. Cimino-Mathews
affiliation:
name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
address:
name:Departments of Pathology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
type:PostalAddress
type:Organization
name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
address:
name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
type:PostalAddress
type:Organization
name:N. Chaher
affiliation:
name:Centre Pierre et Marie Curie et Faculté de Médecine d’Alger
address:
name:Department of Pathology, Centre Pierre et Marie Curie et Faculté de Médecine d’Alger, Algiers, Algeria
type:PostalAddress
type:Organization
name:C. Qualls
affiliation:
name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
address:
name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
type:PostalAddress
type:Organization
name:N. Joste
affiliation:
name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
address:
name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
type:PostalAddress
type:Organization
name:C. Colpaert
affiliation:
name:Iridium Cancer Net
address:
name:Department of Pathology, Oncology Centre, GZA Hospitals, Iridium Cancer Net, Antwerp, Belgium
type:PostalAddress
type:Organization
name:J. D. Marotti
affiliation:
name:Geisel School of Medicine at Dartmouth
address:
name:Pathology and Laboratory Medicine, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
type:Organization
name:M. Foisey
affiliation:
name:Geisel School of Medicine at Dartmouth
address:
name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
type:Organization
name:E. R. Prossnitz
affiliation:
name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
address:
name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
type:PostalAddress
type:Organization
name:L. A. Emens
affiliation:
name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
address:
name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
type:PostalAddress
type:Organization
name:S. Fiering
affiliation:
name:Geisel School of Medicine at Dartmouth
address:
name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
type:PostalAddress
type:Organization
PostalAddress:
name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
name:Departments of Pathology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
name:Department of Pathology, Centre Pierre et Marie Curie et Faculté de Médecine d’Alger, Algiers, Algeria
name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
name:Department of Pathology, Oncology Centre, GZA Hospitals, Iridium Cancer Net, Antwerp, Belgium
name:Pathology and Laboratory Medicine, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(178)
- How much revenue does https://www.springernature.com/gp/authors produce monthly?
- What's https://link.springernature.com/home/'s gross income?
- Get to know what's the income of https://order.springer.com/public/cart
- How much income does https://submission.springernature.com/new-submission/10549/3 have?
- How much does https://orcid.org/0000-0003-4941-1110 pull in?
- See how much https://www.springernature.com/gp/librarians/licensing/agc/journals makes per month
- What are the earnings of https://doi.org/10.1093/jnci/dji172?
- What are the earnings of https://doi.org/10.1093%2Fjnci%2Fdji172?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15998949
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844937's total income per month
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Trends%20in%20Inflammatory%20Breast%20Carcinoma%20Incidence%20and%20Survival%3A%20The%20Surveillance%2C%20Epidemiology%2C%20and%20End%20Results%20Program%20at%20the%20National%20Cancer%20Institute&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdji172&volume=97&issue=13&pages=966-975&publication_year=2005&author=Hance%2CKW&author=Anderson%2CWF&author=Devesa%2CSS&author=Young%2CHA&author=Levine%2CPH
- How much profit is https://doi.org/10.1093/annonc/mdu121 making per month?
- How much profit does https://doi.org/10.1093%2Fannonc%2Fmdu121 generate?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24669011
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432376's total income per month
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Survival%20of%20women%20with%20inflammatory%20breast%20cancer%3A%20a%20large%20population-based%20study&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdu121&volume=25&issue=6&pages=1143-1151&publication_year=2014&author=Dawood%2CS&author=Lei%2CX&author=Dent%2CR&author=Gupta%2CS&author=Sirohi%2CB&author=Cortes%2CJ&author=Cristofanilli%2CM&author=Buchholz%2CT&author=Gonzalez-Angulo%2CAM bring in?
- Earnings of https://doi.org/10.1016/S1470-2045(12)70049-9
- How much income is https://doi.org/10.1016%2FS1470-2045%2812%2970049-9 earning monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22377126 rake in every month?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Neoadjuvant%20bevacizumab%2C%20trastuzumab%2C%20and%20chemotherapy%20for%20primary%20inflammatory%20HER2-positive%20breast%20cancer%20%28BEVERLY-2%29%3A%20an%20open-label%2C%20single-arm%20phase%202%20study&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2812%2970049-9&volume=13&issue=4&pages=375-384&publication_year=2012&author=Pierga%2CJ-Y&author=Petit%2CT&author=Delozier%2CT&author=Ferrero%2CJ-M&author=Campone%2CM&author=Gligorov%2CJ&author=Lerebours%2CF&author=Roch%C3%A9%2CH&author=Bachelot%2CT&author=Charafe-Jauffret%2CE&author=Pavlyuk%2CM&author=Kraemer%2CS&author=Bidard%2CF-C&author=Viens%2CP?
- How much profit does https://doi.org/10.1007/s10549-012-2133-2 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22733221 make?
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291081 generate?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Inflammatory%20and%20non-inflammatory%20breast%20cancer%20survival%20by%20socioeconomic%20position%20in%20the%20Surveillance%2C%20Epidemiology%2C%20and%20End%20Results%20database%2C%201990%E2%80%932008&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-012-2133-2&volume=134&issue=3&pages=1257-1268&publication_year=2012&author=Schlichting%2CJA&author=Soliman%2CAS&author=Schairer%2CC&author=Schottenfeld%2CD&author=Merajver%2CSD?
- How much does https://doi.org/10.1002%2Fcncr.25682 generate monthly?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21509759?
- How much does http://scholar.google.com/scholar_lookup?&title=Differences%20in%20survival%20among%20women%20with%20stage%20III%20inflammatory%20and%20noninflammatory%20locally%20advanced%20breast%20cancer%20appear%20early%3A%20a%20large%20population-based%20study&journal=Cancer&doi=10.1002%2Fcncr.25682&volume=117&issue=9&pages=1819-1826&publication_year=2011&author=Dawood%2CS&author=Ueno%2CN&author=Valero%2CV&author=Woodward%2CW&author=Buchholz%2CT&author=Hortobagyi%2CG&author=Gonzalez-Angulo%2CA&author=Cristofanilli%2CM pull in?
- What's the financial outcome of https://doi.org/10.1634/theoncologist.12-8-904?
- What's the profit of https://doi.org/10.1634%2Ftheoncologist.12-8-904?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17766649 have?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=&journal=Trends%20for%20Inflammatory%20Breast%20Cancer%3A%20Is%20Survival%20Improving%3F%20Oncologist&doi=10.1634%2Ftheoncologist.12-8-904&volume=12&issue=8&pages=904-912&publication_year=2007&author=Gonzalez-Angulo%2CAM&author=Hennessy%2CBT&author=Broglio%2CK&author=Meric-Bernstam%2CF&author=Cristofanilli%2CM&author=Giordano%2CSH&author=Buchholz%2CTA&author=Sahin%2CA&author=Singletary%2CSE&author=Buzdar%2CAU&author=Hortobagyi%2CGN?
- Find out how much https://doi.org/10.1038/nature14011 earns monthly
- How much profit does https://doi.org/10.1038%2Fnature14011 make?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25428504's gross income?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836193?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Predictive%20correlates%20of%20response%20to%20the%20anti-PD-L1%20antibody%20MPDL3280A%20in%20cancer%20patients&journal=Nature&doi=10.1038%2Fnature14011&volume=515&issue=7528&pages=563-567&publication_year=2014&author=Herbst%2CRS&author=Soria%2CJ-C&author=Kowanetz%2CM&author=Fine%2CGD&author=Hamid%2CO&author=Gordon%2CMS&author=Sosman%2CJA&author=McDermott%2CDF&author=Powderly%2CJD&author=Gettinger%2CSN&author=Kohrt%2CHEK&author=Horn%2CL&author=Lawrence%2CDP&author=Rost%2CS&author=Leabman%2CM&author=Xiao%2CY&author=Mokatrin%2CA&author=Koeppen%2CH&author=Hegde%2CPS&author=Mellman%2CI&author=Chen%2CDS&author=Hodi%2CFS make?
- Explore the financials of https://doi.org/10.1056/NEJMoa1200690
- https://doi.org/10.1056%2FNEJMoa1200690 income
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22658127 net monthly?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Safety%2C%20Activity%2C%20and%20Immune%20Correlates%20of%20Anti%E2%80%93PD-1%20Antibody%20in%20Cancer&journal=New%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1200690&volume=366&issue=26&pages=2443-2454&publication_year=2012&author=Topalian%2CSL&author=Hodi%2CFS&author=Brahmer%2CJR&author=Gettinger%2CSN&author=Smith%2CDC&author=McDermott%2CDF&author=Powderly%2CJD&author=Carvajal%2CRD&author=Sosman%2CJA&author=Atkins%2CMB&author=Leming%2CPD&author=Spigel%2CDR&author=Antonia%2CSJ&author=Horn%2CL&author=Drake%2CCG&author=Pardoll%2CDM&author=Chen%2CL&author=Sharfman%2CWH&author=Anders%2CRA&author=Taube%2CJM&author=McMiller%2CTL&author=Xu%2CH&author=Korman%2CAJ&author=Jure-Kunkel%2CM&author=Agrawal%2CS&author=McDonald%2CD&author=Kollia%2CGD&author=Gupta%2CA&author=Wigginton%2CJM&author=Sznol%2CM?
- How much cash flow does https://doi.org/10.1200/jco.2015.64.8931 have monthly?
- Monthly income for https://doi.org/10.1200%2FJCO.2015.64.8931
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27138582's gross income?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Pembrolizumab%20in%20Patients%20With%20Advanced%20Triple-Negative%20Breast%20Cancer%3A%20Phase%20Ib%20KEYNOTE-012%20Study&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2015.64.8931&volume=34&issue=21&pages=2460-2467&publication_year=2016&author=Nanda%2CR&author=Chow%2CLQM&author=Dees%2CEC&author=Berger%2CR&author=Gupta%2CS&author=Geva%2CR&author=Pusztai%2CL&author=Pathiraja%2CK&author=Aktan%2CG&author=Cheng%2CJD&author=Karantza%2CV&author=Buisseret%2CL
- What's the revenue for https://doi.org/10.1038%2Fnm730?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12091876?
- Get to know http://scholar.google.com/scholar_lookup?&title=Tumor-associated%20B7-H1%20promotes%20T-cell%20apoptosis%3A%20A%20potential%20mechanism%20of%20immune%20evasion&journal=Nat%20Med&doi=10.1038%2Fnm730&volume=8&issue=8&pages=793-800&publication_year=2002&author=Dong%2CH&author=Strome%2CSE&author=Salomao%2CDR&author=Tamura%2CH&author=Hirano%2CF&author=Flies%2CDB&author=Roche%2CPC&author=Lu%2CJ&author=Zhu%2CG&author=Tamada%2CK&author=Lennon%2CVA&author=Celis%2CE&author=Chen%2CL's earnings
- What's the income of https://doi.org/10.1016/j.immuni.2013.07.012?
- How much income does https://doi.org/10.1016%2Fj.immuni.2013.07.012 have?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23890059
- http://scholar.google.com/scholar_lookup?&title=Oncology%20Meets%20Immunology%3A%20The%20Cancer-Immunity%20Cycle&journal=Immunity&doi=10.1016%2Fj.immuni.2013.07.012&volume=39&issue=1&pages=1-10&publication_year=2013&author=Chen%20Daniel%2CS&author=Mellman%2CI income
- What's https://doi.org/10.1158/1078-0432.ccr-16-3001's gross income?
- Revenue of https://doi.org/10.1158%2F1078-0432.CCR-16-3001
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28801472
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Breast%20Cancer%20Immunotherapy%3A%20Facts%20and%20Hopes&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.ccr-16-3001&volume=24&issue=3&pages=511-520&publication_year=2018&author=Emens%2CLA?
- What are the earnings of https://doi.org/10.1007/s10549-014-2988-5?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24842267 is on a monthly basis
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180714 pull in monthly?
- http://scholar.google.com/scholar_lookup?&title=Expression%20of%20programmed%20death%20ligand%201%20%28PD-L1%29%20is%20associated%20with%20poor%20prognosis%20in%20human%20breast%20cancer&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-014-2988-5&volume=146&issue=1&pages=15-24&publication_year=2014&author=Muenst%2CS&author=Schaerli%2CAR&author=Gao%2CF&author=D%C3%A4ster%2CS&author=Trella%2CE&author=Droeser%2CRA&author=Muraro%2CMG&author=Zajac%2CP&author=Zanetti%2CR&author=Gillanders%2CWE&author=Weber%2CWP&author=Soysal%2CSD's revenue stream
- How much does https://doi.org/10.1111/his.12904 pull in?
- Get to know what's the income of https://doi.org/10.1111%2Fhis.12904
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26588661 is on a monthly basis
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Programmed%20death%20ligand%201%20expression%20in%20triple-negative%20breast%20cancer%20is%20associated%20with%20tumour-infiltrating%20lymphocytes%20and%20improved%20outcome&journal=Histopathology&doi=10.1111%2Fhis.12904&volume=69&issue=1&pages=25-34&publication_year=2016&author=Beckers%2CRK&author=Selinger%2CCI&author=Vilain%2CR&author=Madore%2CJ&author=Wilmott%2CJS&author=Harvey%2CK&author=Holliday%2CA&author=Cooper%2CCL&author=Robbins%2CE&author=Gillett%2CD&author=Kennedy%2CCW&author=Gluch%2CL&author=Carmalt%2CH&author=Mak%2CC&author=Warrier%2CS&author=Gee%2CHE&author=Chan%2CC&author=McLean%2CA&author=Walker%2CE&author=McNeil%2CCM&author=Beith%2CJM&author=Swarbrick%2CA&author=Scolyer%2CRA&author=O%E2%80%99Toole%2CSA?
- Financial intake of https://doi.org/10.1158/1078-0432.ccr-13-2702
- What's the financial outcome of https://doi.org/10.1158%2F1078-0432.CCR-13-2702?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24647569?
- http://scholar.google.com/scholar_lookup?&title=In%20Situ%20Tumor%20PD-L1%20mRNA%20Expression%20Is%20Associated%20with%20Increased%20TILs%20and%20Better%20Outcome%20in%20Breast%20Carcinomas&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.ccr-13-2702&volume=20&issue=10&pages=2773-2782&publication_year=2014&author=Schalper%2CKA&author=Velcheti%2CV&author=Carvajal%2CD&author=Wimberly%2CH&author=Brown%2CJ&author=Pusztai%2CL&author=Rimm%2CDL's financial summary
- What's the monthly income of https://doi.org/10.18632%2Foncotarget.3216?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25669979?
- How much does http://scholar.google.com/scholar_lookup?&title=Prognostic%20and%20predictive%20value%20of%20PDL1%20expression%20in%20breast%20cancer&journal=Oncotarget&doi=10.18632%2Foncotarget.3216&volume=6&issue=7&pages=5449-5464&publication_year=2015&author=Sabatier%2CR&author=Finetti%2CP&author=Mamessier%2CE&author=Adelaide%2CJ&author=Chaffanet%2CM&author=Ali%2CHR&author=Viens%2CP&author=Caldas%2CC&author=Birnbaum%2CD&author=Bertucci%2CF rake in every month?
- Get to know https://doi.org/10.1158/1078-0432.ccr-14-1622's earnings
- What is the earnings of https://doi.org/10.1158%2F1078-0432.CCR-14-1622?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25255793 bring in?
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252785 generate?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Multiplexed%20Quantitative%20Analysis%20of%20CD3%2C%20CD8%2C%20and%20CD20%20Predicts%20Response%20to%20Neoadjuvant%20Chemotherapy%20in%20Breast%20Cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.ccr-14-1622&volume=20&issue=23&pages=5995-6005&publication_year=2014&author=Brown%2CJR&author=Wimberly%2CH&author=Lannin%2CDR&author=Nixon%2CC&author=Rimm%2CDL&author=Bossuyt%2CV making per month?
- Learn how profitable https://doi.org/10.1200/jco.2010.30.5037 is on a monthly basis
- How much money does https://doi.org/10.1200%2FJCO.2010.30.5037 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21483002 rake in every month?
- How much does http://scholar.google.com/scholar_lookup?&title=Tumor-Infiltrating%20CD8%20%2B%20Lymphocytes%20Predict%20Clinical%20Outcome%20in%20Breast%20Cancer&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2010.30.5037&volume=29&issue=15&pages=1949-1955&publication_year=2011&author=Mahmoud%2CSMA&author=Paish%2CEC&author=Powe%2CDG&author=Macmillan%2CRD&author=Grainge%2CMJ&author=Lee%2CAHS&author=Ellis%2CIO&author=Green%2CAR generate monthly?
- What's the profit of https://doi.org/10.1007/s10549-011-1422-5?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21360074's total income per month
- How much does http://scholar.google.com/scholar_lookup?&title=Molecular%20and%20epidemiological%20characteristics%20of%20inflammatory%20breast%20cancer%20in%20Algerian%20patients&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-011-1422-5&volume=131&issue=2&pages=437-444&publication_year=2012&author=Chaher%2CN&author=Arias-Pulido%2CH&author=Terki%2CN&author=Qualls%2CC&author=Bouzid%2CK&author=Verschraegen%2CC&author=Wallace%2CAM&author=Royce%2CM pull in monthly?
- How much does https://doi.org/10.1093/annonc/mdq345 gross monthly?
- See how much https://doi.org/10.1093%2Fannonc%2Fmdq345 makes per month
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20603440 generate monthly?
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105293's revenue stream
- Find out how much http://scholar.google.com/scholar_lookup?&title=International%20expert%20panel%20on%20inflammatory%20breast%20cancer%3A%20consensus%20statement%20for%20standardized%20diagnosis%20and%20treatment&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdq345&volume=22&pages=515-523&publication_year=2010&author=Dawood%2CS&author=Merajver%2CSD&author=Viens%2CP&author=Vermeulen%2CPB&author=Swain%2CSM&author=Buchholz%2CTA&author=Dirix%2CLY&author=Levine%2CPH&author=Lucci%2CA&author=Krishnamurthy%2CS&author=Robertson%2CFM&author=Woodward%2CWA&author=Yang%2CWT&author=Ueno%2CNT&author=Cristofanilli%2CM earns monthly
- How much does https://doi.org/10.1016/S0140-6736(13)62422-8 gross monthly?
- Get to know what's the income of https://doi.org/10.1016%2FS0140-6736%2813%2962422-8
- How much does http://scholar.google.com/scholar_lookup?&title=Pathological%20complete%20response%20and%20long-term%20clinical%20benefit%20in%20breast%20cancer%3A%20the%20CTNeoBC%20pooled%20analysis&journal=The%20Lancet&doi=10.1016%2FS0140-6736%2813%2962422-8&volume=384&issue=9938&pages=164-172&publication_year=2014&author=Cortazar%2CP&author=Zhang%2CL&author=Untch%2CM&author=Mehta%2CK&author=Costantino%2CJP&author=Wolmark%2CN&author=Bonnefoi%2CH&author=Cameron%2CD&author=Gianni%2CL&author=Valagussa%2CP&author=Swain%2CSM&author=Prowell%2CT&author=Loibl%2CS&author=Wickerham%2CDL&author=Bogaerts%2CJ&author=Baselga%2CJ&author=Perou%2CC&author=Blumenthal%2CG&author=Blohmer%2CJ&author=Mamounas%2CEP&author=Bergh%2CJ&author=Semiglazov%2CV&author=Justice%2CR&author=Eidtmann%2CH&author=Paik%2CS&author=Piccart%2CM&author=Sridhara%2CR&author=Fasching%2CPA&author=Slaets%2CL&author=Tang%2CS&author=Gerber%2CB&author=Geyer%2CCE&author=Pazdur%2CR&author=Ditsch%2CN&author=Rastogi%2CP&author=Eiermann%2CW&author=Minckwitz%2CG pull in?
- Learn about the earnings of https://doi.org/10.1093/annonc/mdu450
- What is the earnings of https://doi.org/10.1093%2Fannonc%2Fmdu450?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25214542?
- http://scholar.google.com/scholar_lookup?&title=The%20evaluation%20of%20tumor-infiltrating%20lymphocytes%20%28TILs%29%20in%20breast%20cancer%3A%20recommendations%20by%20an%20International%20TILs%20Working%20Group%202014&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdu450&volume=26&issue=2&pages=259-271&publication_year=2015&author=Salgado%2CR&author=Denkert%2CC&author=Demaria%2CS&author=Sirtaine%2CN&author=Klauschen%2CF&author=Pruneri%2CG&author=Wienert%2CS&author=Eynden%2CG&author=Baehner%2CFL&author=Penault-Llorca%2CF&author=Perez%2CEA&author=Thompson%2CEA&author=Symmans%2CWF&author=Richardson%2CAL&author=Brock%2CJ&author=Criscitiello%2CC&author=Bailey%2CH&author=Ignatiadis%2CM&author=Floris%2CG&author=Sparano%2CJ&author=Kos%2CZ&author=Nielsen%2CT&author=Rimm%2CDL&author=Allison%2CKH&author=Reis-Filho%2CJS&author=Loibl%2CS&author=Sotiriou%2CC&author=Viale%2CG&author=Badve%2CS&author=Adams%2CS&author=Willard-Gallo%2CK&author=Loi%2CS's total income per month
- What's the revenue for https://doi.org/10.1371/journal.pmed.1001216?
- Explore the financials of https://doi.org/10.1371%2Fjournal.pmed.1001216
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22675273
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362085 income
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Reporting%20Recommendations%20for%20Tumor%20Marker%20Prognostic%20Studies%20%28REMARK%29%3A%20Explanation%20and%20Elaboration&journal=PLOS%20Medicine&doi=10.1371%2Fjournal.pmed.1001216&volume=9&issue=5&publication_year=2012&author=Altman%2CDG&author=McShane%2CLM&author=Sauerbrei%2CW&author=Taube%2CSE?
- How much does https://doi.org/10.1158/1078-0432.ccr-16-1821 net monthly?
- Revenue of https://doi.org/10.1158%2F1078-0432.CCR-16-1821
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28428193
- How much revenue does http://scholar.google.com/scholar_lookup?&title=PD-L1%20Expression%20in%20Melanoma%3A%20A%20Quantitative%20Immunohistochemical%20Antibody%20Comparison&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.ccr-16-1821&volume=23&issue=16&pages=4938-4944&publication_year=2017&author=Sunshine%2CJC&author=Nguyen%2CPL&author=Kaunitz%2CGJ&author=Cottrell%2CTR&author=Berry%2CS&author=Esandrio%2CJ&author=Xu%2CH&author=Ogurtsova%2CA&author=Bleich%2CKB&author=Cornish%2CTC&author=Lipson%2CEJ&author=Anders%2CRA&author=Taube%2CJM generate?
- Earnings of https://doi.org/10.1007/s10549-011-1620-1
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21671016's total income per month
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=The%20prognostic%20significance%20of%20B%20lymphocytes%20in%20invasive%20carcinoma%20of%20the%20breast&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-011-1620-1&volume=132&issue=2&pages=545-553&publication_year=2012&author=Mahmoud%2CSMA&author=Lee%2CAHS&author=Paish%2CEC&author=Macmillan%2CRD&author=Ellis%2CIO&author=Green%2CAR?
- How much does https://doi.org/10.4161/21624011.2014.955691 generate monthly?
- What's the profit of https://doi.org/10.4161%2F21624011.2014.955691?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25941621
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292729?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Consensus%20guidelines%20for%20the%20detection%20of%20immunogenic%20cell%20death&journal=OncoImmunology&doi=10.4161%2F21624011.2014.955691&volume=3&issue=9&publication_year=2014&author=Kepp%2CO&author=Senovilla%2CL&author=Vitale%2CI&author=Vacchelli%2CE&author=Adjemian%2CS&author=Agostinis%2CP&author=Apetoh%2CL&author=Aranda%2CF&author=Barnaba%2CV&author=Bloy%2CN&author=Bracci%2CL&author=Breckpot%2CK&author=Brough%2CD&author=Buqu%C3%A9%2CA&author=Castro%2CMG&author=Cirone%2CM&author=Colombo%2CMI&author=Cremer%2CI&author=Demaria%2CS&author=Dini%2CL&author=Eliopoulos%2CAG&author=Faggioni%2CA&author=Formenti%2CSC&author=Fu%C4%8D%C3%ADkov%C3%A1%2CJ&author=Gabriele%2CL&author=Gaipl%2CUS&author=Galon%2CJ&author=Garg%2CA&author=Ghiringhelli%2CF&author=Giese%2CNA&author=Guo%2CZS&author=Hemminki%2CA&author=Herrmann%2CM&author=Hodge%2CJW&author=Holdenrieder%2CS&author=Honeychurch%2CJ&author=Hu%2CH-M&author=Huang%2CX&author=Illidge%2CTM&author=Kono%2CK&author=Korbelik%2CM&author=Krysko%2CDV&author=Loi%2CS&author=Lowenstein%2CPR&author=Lugli%2CE&author=Ma%2CY&author=Madeo%2CF&author=Manfredi%2CAA&author=Martins%2CI&author=Mavilio%2CD&author=Menger%2CL&author=Merendino%2CN&author=Michaud%2CM&author=Mignot%2CG&author=Mossman%2CKL&author=Multhoff%2CG&author=Oehler%2CR&author=Palombo%2CF&author=Panaretakis%2CT&author=Pol%2CJ&author=Proietti%2CE&author=Ricci%2CJ-E&author=Riganti%2CC&author=Rovere-Querini%2CP&author=Rubartelli%2CA&author=Sistigu%2CA&author=Smyth%2CMJ&author=Sonnemann%2CJ&author=Spisek%2CR&author=Stagg%2CJ&author=Sukkurwala%2CAQ&author=Tartour%2CE&author=Thorburn%2CA&author=Thorne%2CSH&author=Vandenabeele%2CP&author=Velotti%2CF&author=Workenhe%2CST&author=Yang%2CH&author=Zong%2CW-X&author=Zitvogel%2CL&author=Kroemer%2CG&author=Galluzzi%2CL
- What's the income of https://doi.org/10.18632%2Foncotarget.3642?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25940795?
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537030 make?
- How profitable is http://scholar.google.com/scholar_lookup?&title=PDL1%20expression%20in%20inflammatory%20breast%20cancer%20is%20frequent%20and%20predicts%20for%20the%20pathological%20response%20to%20chemotherapy&journal=Oncotarget&doi=10.18632%2Foncotarget.3642&volume=6&issue=15&pages=13506-13519&publication_year=2015&author=Bertucci%2CF&author=Finetti%2CP&author=Colpaert%2CC&author=Mamessier%2CE&author=Parizel%2CM&author=Dirix%2CL&author=Viens%2CP&author=Birnbaum%2CD&author=Laere%2CS?
- Profit of https://doi.org/10.1093/ajcp/aqx162
- How much revenue does https://doi.org/10.1093%2Fajcp%2Faqx162 bring in?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29425258?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Expression%20of%20Programmed%20Death%20Ligand%201%20%28PD-L1%29%20in%20Posttreatment%20Primary%20Inflammatory%20Breast%20Cancers%20and%20Clinical%20Implications&journal=Am%20J%20Clin%20Pathol&doi=10.1093%2Fajcp%2Faqx162&volume=149&issue=3&pages=253-261&publication_year=2018&author=He%2CJ&author=Huo%2CL&author=Ma%2CJ&author=Zhao%2CJ&author=Bassett%2CRL&author=Sun%2CX&author=Ueno%2CNT&author=Lim%2CB&author=Gong%2CY?
- What's the monthly income of https://doi.org/10.1158/1078-0432.ccr-13-3368?
- https://doi.org/10.1158%2F1078-0432.CCR-13-3368's revenue stream
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24916698?
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102637 generate?
- How much money does http://scholar.google.com/scholar_lookup?&title=Prognostic%20B-cell%20Signatures%20Using%20mRNA-Seq%20in%20Patients%20with%20Subtype-Specific%20Breast%20and%20Ovarian%20Cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.ccr-13-3368&volume=20&issue=14&pages=3818-3829&publication_year=2014&author=Iglesia%2CMD&author=Vincent%2CBG&author=Parker%2CJS&author=Hoadley%2CKA&author=Carey%2CLA&author=Perou%2CCM&author=Serody%2CJS make?
- Explore the financials of https://doi.org/10.1186/s13058-017-0884-8
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28784153 rake in every month?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547502 pull in?
- How much does http://scholar.google.com/scholar_lookup?&title=Effect%20of%20neoadjuvant%20chemotherapy%20on%20tumor-infiltrating%20lymphocytes%20and%20PD-L1%20expression%20in%20breast%20cancer%20and%20its%20clinical%20significance&journal=Breast%20Cancer%20Res&doi=10.1186%2Fs13058-017-0884-8&volume=19&issue=1&publication_year=2017&author=Pelekanou%2CV&author=Carvajal-Hausdorf%2CDE&author=Altan%2CM&author=Wasserman%2CB&author=Carvajal-Hausdorf%2CC&author=Wimberly%2CH&author=Brown%2CJ&author=Lannin%2CD&author=Pusztai%2CL&author=Rimm%2CDL net monthly?
- How much does https://doi.org/10.4049/jimmunol.1001323 net monthly?
- How much does https://doi.org/10.4049%2Fjimmunol.1001323 bring in each month?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20962266 generate?
- Get to know http://scholar.google.com/scholar_lookup?&title=CD20%20%2B%20B%20Cells%3A%20The%20Other%20Tumor-Infiltrating%20Lymphocytes&journal=J%20Immunol&doi=10.4049%2Fjimmunol.1001323&volume=185&issue=9&pages=4977-4982&publication_year=2010&author=Nelson%2CBH's earnings
- What's the revenue for https://citation-needed.springer.com/v2/references/10.1007/s10549-018-4834-7?format=refman&flavour=references?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=H.%20Arias-Pulido?
- What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22H.%20Arias-Pulido%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A.%20Cimino-Mathews make?
- What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A.%20Cimino-Mathews%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=N.%20Chaher?
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22N.%20Chaher%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C.%20Qualls?
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C.%20Qualls%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=N.%20Joste
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22N.%20Joste%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C.%20Colpaert income
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C.%20Colpaert%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.%20D.%20Marotti
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.%20D.%20Marotti%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20Foisey
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20Foisey%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=E.%20R.%20Prossnitz earns monthly
- How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22E.%20R.%20Prossnitz%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=L.%20A.%20Emens?
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22L.%20A.%20Emens%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S.%20Fiering?
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S.%20Fiering%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much profit does https://static-content.springer.com/esm/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_MOESM1_ESM.tif make?
- What's https://static-content.springer.com/esm/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_MOESM2_ESM.xlsx's gross income?
- What's the financial gain of https://static-content.springer.com/esm/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_MOESM3_ESM.xlsx?
- What's the financial gain of https://static-content.springer.com/esm/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_MOESM4_ESM.xlsx?
- https://s100.copyright.com/AppDispatchServlet?title=The%20combined%20presence%20of%20CD20%E2%80%89%2B%E2%80%89B%20cells%20and%20PD-L1%E2%80%89%2B%E2%80%89tumor-infiltrating%20lymphocytes%20in%20inflammatory%20breast%20cancer%20is%20prognostic%20of%20improved%20patient%20outcome&author=H.%20Arias-Pulido%20et%20al&contentID=10.1007%2Fs10549-018-4834-7©right=Springer%20Science%2BBusiness%20Media%2C%20LLC%2C%20part%20of%20Springer%20Nature&publication=0167-6806&publicationDate=2018-06-01&publisherName=SpringerNature&orderBeanReset=true income
- How much does https://crossmark.crossref.org/dialog/?doi=10.1007/s10549-018-4834-7 gross monthly?
- How much does https://citation-needed.springer.com/v2/references/10.1007/s10549-018-4834-7?format=refman&flavour=citation generate monthly?
- How much does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral pull in monthly?
- How much profit is https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research making per month?
- What's the income generated by https://www.springernature.com/gp/products each month?
- How much does https://www.springernature.com/gp/librarians gross monthly?
- See how much https://www.springernature.com/gp/societies makes per month
- What's the financial gain of https://www.springernature.com/gp/partners?
- How much does https://www.springer.com/ rake in every month?
- Learn about the earnings of https://www.nature.com/
- How much does https://www.biomedcentral.com/ net monthly?
- Get to know https://www.palgrave.com/'s earnings
- Profit of https://www.apress.com/
- How much revenue does https://www.springernature.com/gp/legal/ccpa bring in?
- What's the financial outcome of https://www.springernature.com/gp/info/accessibility?
- Learn how profitable https://support.springernature.com/en/support/home is on a monthly basis
- How much profit does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations generate?
- What's the revenue for https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref